Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.
Tamiya
Akihiro
A
Endo
Masahiro
M
Shukuya
Takehito
T
Igawa
Satoshi
S
Tsuya
Asuka
A
Nakamura
Yukiko
Y
Murakami
Haruyasu
H
Takahashi
Toshiaki
T
Boku
Narikazu
N
Yamamoto
Nobuyuki
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000188:drug therapy; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011014:Pneumonia / Q000139:chemically induced / Q000473:pathology; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine